Table 4.
In-hospital management and outcomes [21].
| Control Period, (March–April 2019, n=145) | First Wave, (March–April 2020, n=108) | Control vs First Wave | Second Wave, (July–August 2020, n=82) | Control vs. Second Wave | |
|---|---|---|---|---|---|
| Angiogram during index admission | 109 (75.2%) | 95 (88%) | p=0.02 | 73 (89%) | p=0.01 |
| PCI during index admission | 63 (43.4%) | 64 (59.3%) | p=0.02 | 53 (64.6%) | p<0.001 |
| CABG referral from admission | 11 (7.6%) | 15 (13.9%) | p=0.14 | 13 (15.9%) | p=0.07 |
| Index revascularisation | 74 (54.5%) | 79 (68.5%) | p<0.001 | 61 (74.4%) | p<0.001 |
| Death | 9 (6.2%) | 5 (4.6%) | p=0.78 | 6 (10.3%) | p=0.08 |
| 30-d myocardial infarction | 5 (3.5%) | 3 (2.8%) | p=0.99 | 1 (1.7%) | p=0.99 |
| 30-d revascularisation | 2 (1.4%) | 1 (0.9%) | p=0.99 | 1 (1.7%) | p=0.46 |
| 30-d MACE | 14 (9.6%) | 8 (7.4%) | p=0.65 | 8 (9.7%) | p=0.99 |
| Peak measured troponin I (ng/L) n<16 ng/L for women, n<26 ng/L for men | 2,019 (126–14,505) | 2,057 (175–20,710) | p=0.83 | 3,652 (753–41,033) | p=0.02 |
| Admitted ICU | 6 (4.1%) | 2 (1.9%) | p=0.47 | 5 (6.1%) | p=0.53 |
Abbreviations: PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; MACE, major adverse cardiac event.